相关实验视频
Updated: May 5, 2026

16:31
Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock
Published on: June 6, 2011
24.7K
IL-1β原始化中细胞 stromal 细胞中等出血性冲击诱导的血管透性
Nathalie Baudry1, Aurélie Campeanu1,2,3, Clotilde Aussel2,3
1Laboratoire d'Etude de La Microcirculation, UMRS 942 INSERM, Université Paris Cité, Paris, France.
Journal of translational medicine
|December 24, 2024
概括
用IL-1β (MSCp) 启动的半机体 stromal 细胞 (MSCs) 显示出在出血性休克 (HS) 后预防器官损伤的潜力. 通过抑制内皮功能障碍,MSCp治疗减少了肝损伤和血管泄漏,为HS并发症提供了有前途的治疗途径.
科学领域:
- 创伤和紧急医疗医学
- 细胞和分子生物学 细胞和分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 出血性休克 (HS) 会导致低血压,血液静止受损,炎症和微血管透性,可能导致多器官衰竭 (MOF).
- 内皮功能障碍是HS后MOF发展的关键因素,目前没有特定的治疗方法可用.
- 介酶体 stromal 细胞 (MSCs) 具有免疫调节和组织修复的特性,而 IL-1β-primed MSCs (MSCp) 之前已经在减轻HS诱导的器官损伤方面表现有前途.
研究的目的:
- 通过向内皮功能障碍,调查MSCp的使用是否可以通过向内皮功能障碍来预防HS后的MOF.
- 评估MSCp在缓解HS引起的器官损伤方面的治疗潜力.
主要方法:
- 建立了HS的老鼠模型,涉及90分钟的休克,随后是复苏和输血.
- 在复苏开始时,MSCp治疗被静脉注射.
- 复苏后的评估包括血内皮标记物,血管透性 (埃文斯蓝色染料),器官含水量以及体外白细胞-内皮细胞粘附测试.
主要成果:
- 早期MSCp的使用显著降低了肝脏的水含量和埃文斯蓝色染料的扩散,表明肝血管泄漏减少.
- 观察到一种趋势,即内皮标记物 (Syndecan-1,ICAM-1,vWF,VCAM-1) 的血水平下降.
- 实验室研究表明,MSCp抑制白细胞对激活的内皮细胞的粘附,这表明减少炎症的机制.
结论:
- MSCp治疗有效地减轻了内皮功能障碍和血管泄漏,特别是在肝脏,在出血性休克后.
- 这些发现表明,MSCp可以通过保持内皮完整性来保护器官,如肝脏,免受HS诱导的损伤.
- MSCp代表了一种潜在的治疗策略,用于管理与出血性休克相关的并发症.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Regulation of Hematopoietic Stem Cells
3.5K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.5K
Vascular Spasm
4.9K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
4.9K
Acute Inflammation II: Local and Systemic Effects
82
Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
82
Hemorrhagic Stroke ll: Pathophysiology
52
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
52

